BIOMAT Database Logo BIOMAT Database Logo

Biopharmaceutical properties of solid dosage forms. 1967

R A Chapman

UI MeSH Term Description Entries

Related Publications

R A Chapman
Biopharmaceutical properties of solid dosage forms.
July 1967, Canadian Medical Association journal,
R A Chapman
Biopharmaceutical properties of solid dosage forms.
July 1967, Canadian Medical Association journal,
R A Chapman
Design of Dosage Forms with Improved Biopharmaceutical Properties.
January 2024, Pharmaceutics,
R A Chapman
The biopharmaceutical properties of solid dosage forms. I. An evaluation of 23 brands of phenylbutazone tablets.
June 1967, Canadian Medical Association journal,
R A Chapman
[Biopharmaceutical aspects of oral dosage forms].
September 1974, Pharmazie in unserer Zeit,
R A Chapman
Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.
December 2013, Pharmaceutical research,
R A Chapman
Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements.
February 2018, Drug discovery today,
R A Chapman
[Biopharmaceutical study of new oral dosage forms of indomethacin].
January 1983, Journal de pharmacie de Belgique,
R A Chapman
Biopharmaceutical aspects of the design of steroidal dosage forms.
August 1973, Die Pharmazie,
R A Chapman
[Comparative biopharmaceutical study of dosage forms with senna extract].
January 1977, Farmatsiia,
Copied contents to your clipboard!